Erin H Doyle
Overview
Explore the profile of Erin H Doyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doyle E, Aloman C, El-Shamy A, Eng F, Kim-Schulze S, Rahman A, et al.
Liver Transpl
. 2024 Feb;
30(7):728-741.
PMID: 38315053
Chronic HCV infection induces interferon and dysregulates immune responses through inflammation and chronic antigenic stimulation. Antiviral drugs can cure HCV, providing a unique opportunity to examine the immunological restoration that...
2.
Rocha C, Doyle E, Bowman C, Fiel M, Stueck A, Goossens N, et al.
Cancer Med
. 2023 Apr;
12(9):10175-10186.
PMID: 37078924
Background: Successful treatment of hepatitis C reduces liver inflammation and fibrosis; however, patients remain at risk of developing hepatocellular carcinoma (HCC). Aims: To identify risk factors for new-onset HCC in...
3.
Doyle E, Aloman C, El-Shamy A, Eng F, Rahman A, Klepper A, et al.
Sci Rep
. 2021 Jan;
11(1):1551.
PMID: 33452360
Viral hepatitis leads to immune-mediated liver injury. The rate of disease progression varies between individuals. We aimed to phenotype immune cells associated with preservation of normal liver function during hepatitis...
4.
Eng F, El-Shamy A, Doyle E, Klepper A, Muerhoff A, Branch A
Hepatol Commun
. 2018 Feb;
2(1):21-28.
PMID: 29404509
Hepatitis C virus (HCV) is one of the most prevalent causes of chronic blood-borne infections worldwide. Despite developments of highly effective treatments, most infected individuals are unaware of their infection....
5.
Klepper A, Eng F, Doyle E, El-Shamy A, Rahman A, Fiel M, et al.
Hepatology
. 2016 Sep;
66(2):357-370.
PMID: 27642141
Conclusion: HCV dsRNA is the predominant form in the HCV-infected liver and has features of both a PAMP and a genomic reservoir. Interferon treatment increased rather than decreased HCV dsRNA....
6.
El-Shamy A, Pendleton M, Eng F, Doyle E, Bashir A, Branch A
Sci Rep
. 2016 Jun;
6:27025.
PMID: 27246310
Mutations at positions 70 and/or 91 in the core protein of genotype-1b, hepatitis C virus (HCV) are associated with hepatocellular carcinoma (HCC) risk in Asian patients. To evaluate this in...
7.
El-Shamy A, Eng F, Doyle E, Klepper A, Sun X, Sangiovanni A, et al.
J Hepatol
. 2015 Jul;
63(6):1323-33.
PMID: 26220749
Background & Aims: Although patients infected by genotype 1b hepatitis C virus (HCV) with Q(70) and/or M(91)core gene mutations have an almost five-fold increased risk of developing hepatocellular carcinoma (HCC)...
8.
Chang J, Woods M, Lindsay R, Doyle E, Griesbeck M, Chan E, et al.
J Infect Dis
. 2013 Jun;
208(5):830-8.
PMID: 23757341
Background: Clinical studies have shown faster disease progression and stronger immune activation in human immunodeficiency virus (HIV)-1-infected females when compared with males for the same level of HIV-1 replication. Here...
9.
Chang J, Lacas A, Lindsay R, Doyle E, Axten K, Pereyra F, et al.
AIDS
. 2012 Jan;
26(5):533-41.
PMID: 22210629
Objective And Design: The objective of this study was to determine changes in toll-like receptor (TLR) responses of monocytes, myeloid dendritic cells and plasmacytoid dendritic cells during primary and chronic...